ACRV- Acrivon Therapeutics, Inc.
Acrivon Therapeutics, Inc. (ACRV) has 7 insiders with recent SEC Form 4 filings, including 5 buys and 10 sells. ACRV is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.10M | $3.52M | - | |
| Other | 225.0K | $378.0K | - | |
| COO | 75.3K | $126.5K | - | |
| Other | 33.1K | $55.6K | - | |
| CFO | 21.0K | $35.3K | - |
Activity
Buys and sells only
Transactions
10 filings
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 14, 2026 | Blume-Jensen Peter | President And CEO | Buy | 49,000 | $1.68 | $82,124.00 | +2.4% | -14.8% | - | |
| Jan 14, 2026 | Levy Adam D. | Chief Financial Officer | Buy | 8,832 | $1.70 | $14,999.39 | +72.7% | -14.8% | - | |
| Jan 13, 2026 | Devroe Eric | Chief Operating Officer | Buy | 10,000 | $1.72 | $17,218.00 | +15.3% | -8.2% | - | |
| May 1, 2025 | Perceptive Advisors LLC51 | 10% Owner | Sell | 736,767 | $1.38 | $1,017,919.45 | -10.2% | -0.8% | +57.1% | |
| Apr 29, 2025 | Perceptive Advisors LLC51 | 10% Owner | Sell | 1,519,952 | $1.81 | $2,744,946.03 | -11.0% | -0.7% | - | |
| Apr 11, 2024 | Perceptive Advisors LLC51 | 10% Owner | Buy | 2,353,000 | $8.50 | $20,000,500.00 | +78.2% | -22.9% | -82.6% | |
| Jun 26, 2023 | Chione Ltd61 | 10% Owner | Sell | 16 | $12.93 | $206.88 | - | -29.9% | -53.6% | |
| Jun 15, 2023 | Chione Ltd61 | 10% Owner | Sell | 2,056 | $12.14 | $24,959.84 | - | -8.0% | -39.3% | |
| Jun 14, 2023 | Chione Ltd61 | 10% Owner | Sell | 5,893 | $12.29 | $72,412.09 | - | -6.3% | -34.4% | |
| Nov 17, 2022 | Chione Ltd61 | 10% Owner | Buy | 400,000 | $12.50 | $5,000,000.00 | +11.6% | +43.1% | -75.3% |
Page 1Next →